Aflac Inc Stock Price, News & Analysis

Aflac Incorporated (NYSE: AFL) reported strong Q2 2024 results, with net earnings of $1.8 billion, or $3.10 per diluted share, up from $1.6 billion a year ago. Adjusted earnings increased 8.5% to $1.0 billion, with adjusted EPS rising 15.8% to $1.83. Total revenues were $5.1 billion, slightly down from $5.2 billion in Q2 2023. The company saw positive performance in both Japan and U.S. segments, with Japan's pretax adjusted earnings increasing 18.6% in yen terms and U.S. pretax adjusted earnings up 3.8%. Aflac maintained its commitment to shareholders, declaring a Q3 dividend of $0.50 per share and repurchasing $800 million in shares during Q2.

USAA, a leading provider of financial services for U.S. military members, veterans, and their families, has announced a new partnership with Aflac, the leading supplemental insurance provider in the U.S. This collaboration aims to expand insurance options for USAA members, offering greater financial security.

USAA members will now have access to Aflac's supplemental insurance products, including Accident Insurance, Cancer Insurance, and Critical Illness Insurance. These plans are designed to complement existing health insurance benefits and help manage financial impacts of unexpected health events.

The partnership combines USAA's dedication to military families with Aflac's expertise in supplemental insurance, aiming to provide enhanced value and support to USAA members. Members can access information about these new insurance options at usaa.com/supplemental.

Aflac Incorporated, in partnership with Sunrise Association, delivered over 75 My Special Aflac Ducks to children at Horizon Day Camp–Metro DC. This free robotic companion, designed for pediatric cancer patients, helps children prepare for medical procedures and communicate their feelings. Aflac also contributed $70,000 to support the camp.

Since 2019, Aflac has distributed more than 31,000 ducks free of charge. A recent clinical study by Emory University showed that the duck helps pediatric patients cope with treatment-related distress and anxiety. The duck has received recognition, including being named one of Time Magazine's 50 Best Inventions.

This initiative is part of Aflac's nearly 30-year, $183 million commitment to pediatric cancer and blood disorder support. The program continues to expand in the U.S., Japan, and Northern Ireland.

Aflac has partnered with SKYGEN to enhance its Dental and Vision customer experience. SKYGEN, a technology leader in dental and vision insurance, serves nearly 50 million members across the U.S. This collaboration aims to improve customer satisfaction through advanced automation in claims and billing processes, thus supporting Aflac's growth. The SKYGEN Dental Hub will provide a unified platform for providers, insurers, and patients, streamlining connectivity and improving user experience. Members will benefit from better identification of providers and services, educational resources, and access to administrative data via SKYGEN's member portal. This partnership is expected to boost customer retention and sales growth as satisfied customers may consider other Aflac products.

Aflac, a leading healthcare insurance company operating predominantly in Japan, has promoted its first female executive in the country, underscoring its commitment to workplace equality and diversity. CEO Dan Amos emphasized the importance of having more women in leadership roles, noting that women were underrepresented in executive positions despite Aflac Japan constituting nearly 70% of the company's business. The promotion is aligned with Aflac's broader strategy to foster an inclusive work environment, reflecting its corporate values of equality and diversity.

On June 28, 2024, Coach Dawn Staley partnered with Aflac to distribute 16 My Special Aflac Ducks to sickle cell patients at Prisma Health Children's Hospital-Midlands. The robotic ducks, designed with input from children, families, and medical professionals, help young patients cope with medical treatments. Recognized by Time Magazine and CES, the ducks provide emotional support through lifelike interactions and art therapy. Since 2018, Aflac has donated over 30,000 ducks to children in the U.S., Japan, and Northern Ireland, expanding to include sickle cell patients in 2022. Aflac has contributed more than $182 million to pediatric cancer and blood disorder research since 1995.

Aflac will release its Q2 2024 financial results on July 31, 2024, post-market close. The earnings materials, including the release and financial supplement, will be accessible on the company's Investor Relations website. Additionally, a financial update video by CFO Max Brodén will be available.

Aflac will host a webcast on August 1, 2024, at 8:00 a.m. ET, featuring CEO Daniel P. Amos and Brodén, who will discuss the quarterly results, outlook, and answer questions. Investors can register for the webcast on the company's Investor Relations site.

On June 26, 2024, Deion 'Coach Prime' Sanders partnered with Aflac to deliver My Special Aflac Ducks to pediatric patients at Children's Hospital Colorado. These robotic ducks assist children with cancer and sickle cell disease by providing comfort and helping them manage medical procedures and emotions. Since its launch in 2018, over 31,000 ducks have been distributed across the U.S., Japan, and Northern Ireland. A recent study by Emory University confirmed the duck's effectiveness in reducing anxiety and distress in young patients. Aflac, a leading supplemental health insurance provider, has a longstanding commitment to pediatric cancer and blood disorder support.

On June 25, 2024, Aflac partnered with Hall of Fame athlete and University of Colorado Boulder Head Football Coach Deion "Coach Prime" Sanders to distribute My Special Aflac Ducks at Children's Hospital Colorado. The social robotic duck aims to comfort pediatric patients with cancer and sickle cell disease by helping them prepare for medical procedures and practice distraction techniques. Designed in collaboration with over 100 children, families, and medical professionals, these ducks have been clinically proven to reduce anxiety and distress. Since its launch in 2018, Aflac has distributed nearly 31,000 ducks worldwide. The event featured a scavenger hunt, bringing joy to the young patients, and highlighted Aflac's continued commitment to supporting pediatric cancer and blood disorder treatments with over $182 million in contributions since 1995.